期刊文献+

持续炎症-免疫抑制-分解代谢综合征研究新进展 被引量:3

New research progress of persistent inflammation-immunosuppression-catabolic syndrome
原文传递
导出
摘要 持续炎症-免疫抑制-分解代谢综合征(persistent inflammation immunosuppression catabolism syndrome,PICS)是指机体在严重创伤、感染、烧伤等重大疾病打击后发展为慢性危重病(chronic critical illness,CCI)阶段,表现出以持续性炎症反应、免疫抑制、蛋白质高分解代谢为特征的一组临床症候群。 Persistent inflammatory-immunosuppressive-catabolic syndrome(PICS) is a group of clinical syndromes characterized by persistent inflammatory response, immunosuppression and the protein catabolic responses, which develops into chronic critical illness(CCI) after severe trauma, infection, burn and other major diseases. Because its pathogenesis is complex and clinical prevention and treatment is difficult, PICS is the main cause of prolonged hospitalization and long-term death of patients in intensive care unit(ICU). The decline of their quality of life requires long-term acute cares(LTACs), and will eventually experience chronic failure and death. However, the pathogenesis of PICS is complex, clinicians are relatively lack of awareness and vigilance of PICS, resulting in a high incidence and poor long-term prognosis. Therefore, how to improve clinicians’ vigilance to PICS and effectively improve the survival rate of patients after discharge has become a great challenge for contemporary medicine. The main purpose of this paper is to summarize the pathogenesis, diagnosis and treatment strategies of PICS by combing the understanding of PICS at home and abroad, and thus improve clinicians’ understanding of PICS and provide new ideas for prevention and treatment.
作者 李辉凤 王铭 潘险峰 LI Huifeng;WANG Ming;PAN Xianfeng
出处 《临床急诊杂志》 CAS 2022年第3期219-224,共6页 Journal of Clinical Emergency
关键词 持续炎症-免疫抑制-分解代谢综合征 慢性危重病 炎症 免疫抑制 persistent inflammatory immunosuppressive-catabolic syndrome chronic critical illness inflammation immunosuppression
  • 相关文献

参考文献7

二级参考文献134

  • 1Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immuno12002; 20:197-216.
  • 2Chen GY, Nunez G. Sterile inflammation: sensing and react- ing to damage. Nat Rev lmmuno12010; 10:826-837.
  • 3Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. JGen Physiol 1927; 8:519-530.
  • 4Sbarra AJ, Karnovsky ML. The biochemical basis of phago- cytosis. I. Metabolic changes during the ingestion of parti- cles by polymorphonuclear leukocytes. J Biol Chem 1959; 234:1355-1362.
  • 5Guthrie LA, McPhail LC, Henson PM, Johnston Jr RB. Prim- ing of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased ac- tivity of the superoxide-producing enzyme. J Exp Med 1984; 160:1656-1671.
  • 6Borregaard N, Herlin T. Energy metabolism of human neutro- phils during phagocytosis. J Clin Invest 1982; 70:550-557.
  • 7Hard GC. Some biochemical aspects of the immune macro- phage. BrJExp Pathol 1970; 51:97-105.
  • 8Newsholme P, Gordon S, Newsholme EA. Rates of utiliza- tion and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J 1987; 242:631-636.
  • 9Newsholme P, Curi R, Gordon S, Newsholme EA. Metabo- lism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem J 1986; 239:121- 125.
  • 10Krawczyk CM, Holowka T, Sun J, et al. Toll-like receptor-in- duced changes in glycolytic metabolism regulate dendritic cell activation. Blood 2010; 115:4742-4749.

共引文献152

同被引文献36

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部